Richard Newitter
Stock Analyst at Truist Securities
(3.71)
# 768
Out of 5,237 analysts
471
Total ratings
47.35%
Success rate
8.21%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SIBN SI-BONE | Reiterates: Buy | $20 → $18 | $13.28 | +35.54% | 3 | May 12, 2026 | |
| TNDM Tandem Diabetes Care | Reiterates: Buy | $35 → $31 | $14.69 | +111.03% | 7 | May 11, 2026 | |
| LNTH Lantheus Holdings | Reiterates: Buy | $98 → $115 | $93.91 | +22.46% | 25 | May 11, 2026 | |
| PODD Insulet | Maintains: Buy | $315 → $250 | $158.17 | +58.06% | 7 | May 7, 2026 | |
| INSP Inspire Medical Systems | Maintains: Hold | $64 → $50 | $43.54 | +14.84% | 33 | May 5, 2026 | |
| SYK Stryker | Reiterates: Hold | $380 → $330 | $286.79 | +15.07% | 27 | May 4, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | $98 → $92 | $80.56 | +14.20% | 33 | Apr 29, 2026 | |
| EW Edwards Lifesciences | Maintains: Hold | $89 → $90 | $78.13 | +15.19% | 24 | Apr 24, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $85 | $53.70 | +58.29% | 24 | Apr 23, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $200 → $170 | $118.78 | +43.13% | 21 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $42 | $32.84 | +27.89% | 7 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $95 | $74.92 | +26.80% | 20 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $650 → $580 | $425.03 | +36.46% | 33 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $9.83 | +83.11% | 3 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $18 | $9.78 | +84.05% | 7 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $30 | $27.00 | +11.11% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $19 → $20 | $17.18 | +16.41% | 11 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $97 | $85.84 | +13.01% | 13 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $82 → $80 | $59.80 | +33.78% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $370 → $374 | $323.05 | +15.77% | 8 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $3 | $2.04 | +47.06% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $135.08 | +7.34% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $76.06 | +38.05% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $13.66 | +9.85% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $129.91 | +5.46% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $5.60 | +257.14% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $62.82 | +30.53% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $145.30 | +72.06% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $2.35 | +1,006.38% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $164.29 | +368.68% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $5.72 | +249.65% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $41.08 | -34.27% | 5 | Feb 23, 2021 |
SI-BONE
May 12, 2026
Reiterates: Buy
Price Target: $20 → $18
Current: $13.28
Upside: +35.54%
Tandem Diabetes Care
May 11, 2026
Reiterates: Buy
Price Target: $35 → $31
Current: $14.69
Upside: +111.03%
Lantheus Holdings
May 11, 2026
Reiterates: Buy
Price Target: $98 → $115
Current: $93.91
Upside: +22.46%
Insulet
May 7, 2026
Maintains: Buy
Price Target: $315 → $250
Current: $158.17
Upside: +58.06%
Inspire Medical Systems
May 5, 2026
Maintains: Hold
Price Target: $64 → $50
Current: $43.54
Upside: +14.84%
Stryker
May 4, 2026
Reiterates: Hold
Price Target: $380 → $330
Current: $286.79
Upside: +15.07%
Zimmer Biomet Holdings
Apr 29, 2026
Reiterates: Hold
Price Target: $98 → $92
Current: $80.56
Upside: +14.20%
Edwards Lifesciences
Apr 24, 2026
Maintains: Hold
Price Target: $89 → $90
Current: $78.13
Upside: +15.19%
Boston Scientific
Apr 23, 2026
Maintains: Buy
Price Target: $90 → $85
Current: $53.70
Upside: +58.29%
iRhythm Holdings
Apr 15, 2026
Maintains: Buy
Price Target: $200 → $170
Current: $118.78
Upside: +43.13%
Apr 15, 2026
Maintains: Buy
Price Target: $48 → $42
Current: $32.84
Upside: +27.89%
Apr 15, 2026
Maintains: Hold
Price Target: $103 → $95
Current: $74.92
Upside: +26.80%
Apr 15, 2026
Maintains: Buy
Price Target: $650 → $580
Current: $425.03
Upside: +36.46%
Apr 15, 2026
Maintains: Buy
Price Target: $20 → $18
Current: $9.83
Upside: +83.11%
Apr 15, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $9.78
Upside: +84.05%
Mar 2, 2026
Maintains: Buy
Price Target: $47 → $30
Current: $27.00
Upside: +11.11%
Mar 2, 2026
Maintains: Hold
Price Target: $19 → $20
Current: $17.18
Upside: +16.41%
Feb 20, 2026
Maintains: Buy
Price Target: $95 → $97
Current: $85.84
Upside: +13.01%
Feb 17, 2026
Reiterates: Buy
Price Target: $82 → $80
Current: $59.80
Upside: +33.78%
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $323.05
Upside: +15.77%
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $2.04
Upside: +47.06%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $135.08
Upside: +7.34%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $76.06
Upside: +38.05%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $13.66
Upside: +9.85%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $129.91
Upside: +5.46%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $5.60
Upside: +257.14%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $62.82
Upside: +30.53%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $145.30
Upside: +72.06%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $2.35
Upside: +1,006.38%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $164.29
Upside: +368.68%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $5.72
Upside: +249.65%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $41.08
Upside: -34.27%